An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

NCT04563338 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Non-small Cell Lung Cancer Metastatic
Liver Metastases

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

University Health Network, Toronto

Collaborators

[object Object]